Back to Search
Start Over
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
- Source :
-
Journal of Headache & Pain . 5/17/2022, Vol. 23 Issue 1, p1-4. 4p. - Publication Year :
- 2022
-
Abstract
- A correction to the article "Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: Pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies" that was published in a 2021 issue is presented.
Details
- Language :
- English
- ISSN :
- 11292369
- Volume :
- 23
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Headache & Pain
- Publication Type :
- Academic Journal
- Accession number :
- 156932176
- Full Text :
- https://doi.org/10.1186/s10194-022-01423-x